GlassScriptPhysician profile
Dina Hok
NPI 1316261936
$24,661.22
in general payments reported to CMS, 2019-2025
86 companies · $4,426 in 2025
The $4,426 reported for 2025 was more than what 98% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,853 · 2022: $3,321 · 2023: $3,744 · 2024: $7,318 · 2025: $4,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,130.20 |
| Education | $357.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,512.82 | 2021-2025 | |
| Janssen Biotech, INC. | $1,492.09 | 2021-2025 | Tecvayli, Darzalex, Talvey |
| Astrazeneca Pharmaceuticals LP | $1,480.00 | 2021-2025 | Calquence, Imfinzi, Enhertu |
| Incyte Corporation | $1,467.89 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Merck Sharp & Dohme LLC | $1,383.50 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Takeda Pharmaceuticals U.S.A., INC. | $929.62 | 2021-2025 | Fruzaqla, Alunbrig, Iclusig |
| Eisai INC. | $903.44 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $764.80 | 2021-2025 | |
| Lilly USA, LLC | $703.24 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Amgen INC. | $671.95 | 2021-2023 | Nplate, Xgeva, Vectibix |
| Genzyme Corporation | $600.70 | 2021-2025 | |
| Abbvie INC. | $587.87 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $580.52 | 2021-2025 | Opdivo, Opdualag |
| Celgene Corporation | $561.07 | 2021-2025 | Pomalyst, Reblozyl, Opdualag |
| Gilead Sciences, INC. | $557.42 | 2022-2025 | Trodelvy |
Show all 86 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $549.85 | 2021-2024 | Xtandi, Padcev, Xospata |
| Regeneron Healthcare Solutions, INC. | $525.70 | 2021-2025 | Libtayo |
| Daiichi Sankyo INC. | $524.95 | 2021-2025 | Enhertu, Datroway |
| Puma Biotechnology, INC. | $514.00 | 2021-2025 | Nerlynx |
| Glaxosmithkline, LLC. | $503.93 | 2021-2025 | Ojjaara, Blenrep, Shingrix |
| Genentech USA, INC. | $463.75 | 2021-2025 | Tecentriq, Itovebi, Phesgo |
| Exelixis INC. | $448.37 | 2023-2025 | Cabometyx |
| Karyopharm Therapeutics INC. | $419.14 | 2021-2025 | Xpovio |
| Beigene USA, INC. | $375.66 | 2021-2025 | Brukinsa, Tevimbra |
| Pfizer INC. | $371.66 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $354.94 | 2021-2025 | Gilotrif |
| Pharmacyclics LLC, An Abbvie Company | $351.15 | 2021-2023 | Imbruvica, Epkinly |
| Seagen INC. | $343.68 | 2021-2023 | Adcetris, Tivdak |
| Taiho Oncology, INC. | $338.62 | 2021-2025 | |
| Coherus Oncology, INC. | $298.29 | 2021-2025 | Loqtorzi |
| Alexion Pharmaceuticals, INC. | $249.83 | 2021-2024 | Ultomiris |
| Sumitomo Pharma America, INC. | $245.51 | 2023-2025 | Orgovyx |
| Emd Serono, INC. | $243.52 | 2021-2025 | |
| Aveo Pharmaceuticals, INC. | $232.89 | 2021-2025 | Fotivda |
| Ipsen Biopharmaceuticals, INC | $230.47 | 2021-2025 | Somatuline Depot, Onivyde |
| Blueprint Medicines Corporation | $204.96 | 2021-2025 | Ayvakit |
| Rigel Pharmaceuticals, INC. | $178.69 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Sanofi-Aventis U.S. LLC | $169.94 | 2021-2024 | |
| Sobi, INC | $139.92 | 2024-2025 | |
| Morphosys, US INC. | $122.44 | 2021-2023 | Monjuvi |
| Deciphera Pharmaceuticals INC. | $115.88 | 2021-2023 | Qinlock |
| Stemline Therapeutics INC. | $115.61 | 2022-2024 | Orserdu |
| Organon LLC | $96.92 | 2025 | Ontruzant |
| Dova Pharmaceuticals | $96.09 | 2021 | |
| Myovant Sciences INC. | $94.33 | 2021-2022 | |
| Acrotech Biopharma INC. | $86.11 | 2022 | |
| Ge Healthcare | $85.94 | 2021-2025 | |
| Mirati Therapeutics, INC. | $81.13 | 2023-2024 | Krazati |
| Genmab U.S., INC. | $75.72 | 2024-2025 | Epkinly |
| Tersera Therapeutics LLC | $71.40 | 2021-2025 | Zoladex |
| Novocure INC. | $61.71 | 2021-2025 | Optune Lua (Novottf-200t) |
| Adc Therapeutics America, INC. | $59.50 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $57.54 | 2023-2025 | Provenge |
| Servier Pharmaceuticals LLC | $55.65 | 2021-2024 | |
| Array Biopharma INC | $45.89 | 2025 | Mektovi, Xalkori, Lorbrena |
| Recordati_rare_diseases_inc. | $45.10 | 2024 | Sylvant |
| Foundation Medicine, INC. | $44.95 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $44.54 | 2021 | |
| Spectrum Pharmaceuticals INC. | $43.48 | 2025 | Rolvedon |
| Global Blood Therapeutics, INC. | $39.59 | 2021 | |
| Alnylam Pharmaceuticals INC. | $38.60 | 2022-2025 | Givlaari |
| Emmaus Medical, INC. | $37.22 | 2021-2023 | Endari |
| Secura Bio, INC. | $35.55 | 2021 | |
| Eusa Pharma (US) LLC | $34.45 | 2021 | |
| Progenics Pharmaceuticals, INC. | $31.68 | 2025 | |
| Pharmaessentia USA Corporation | $31.40 | 2024 | Besremi |
| Legend Biotech USA INC. | $30.78 | 2025 | Carvykti |
| Fresenius Kabi USA, LLC | $30.74 | 2025 | |
| Sun Pharmaceutical Industries INC. | $30.70 | 2024 | |
| Tempus Ai, INC | $29.48 | 2024 | |
| Agios Pharmaceuticals, INC. | $27.99 | 2023 | Pyrukynd |
| Geron Corporation | $27.32 | 2025 | Rytelo |
| Syndax Pharmaceuticals, INC. | $25.82 | 2025 | |
| Iovance Biotherapeutics, INC. | $24.94 | 2025 | Amtagvi |
| Amag Pharmaceuticals, INC. | $23.94 | 2021 | |
| G1 Therapeutics, INC. | $23.81 | 2022 | |
| Kyowa Kirin, INC. | $23.30 | 2025 | |
| Amneal Pharmaceuticals LLC | $20.71 | 2025 | Pemrydi Rtu |
| Pharmacosmos Therapeutics INC. | $17.58 | 2025 | Monoferric |
| Kite Pharma, INC. | $17.54 | 2021 | |
| Epizyme, INC. | $16.77 | 2022 | |
| Octapharma USA, INC. | $15.40 | 2022 | |
| Shorla Oncology INC. | $15.12 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $14.51 | 2025 | Akynzeo |
| Jazz Pharmaceuticals INC. | $13.36 | 2021 | |
| Janssen Pharmaceuticals, INC | $6.64 | 2021 |
Drugs and devices associated with these payments
Keytruda $938Lenvima $788Jakafi $655Enhertu $553Jaypirca $506Verzenio $493Imbruvica $452Cabometyx $448Calquence $440Nubeqa $422Epkinly $395Libtayo $347Monjuvi $316Kisqali $304Orgovyx $303Xpovio $291Tecvayli $275Xofigo $273Sarclisa $252Retevmo $243Fruzaqla $239Xtandi $238Ojjaara $232Imfinzi $230Lynparza $228Lonsurf $215Inqovi $215Scemblix $204Pluvicto $204Brukinsa $202Darzalex $198Tecentriq $197Talvey $190Pemazyre $189Welireg $179Udenyca $170Gilotrif $170Padcev $170Somatuline Depot $169Onivyde $169Alunbrig $169Erleada $166Fotivda $152Nerlynx $146Mekinist $142Fabhalta $138Trodelvy $135Ibrance $134Opdivo $128Ayvakit $126Reblozyl $126Rezlidhia $120Tavalisse $120Opdualag $113Akeega $110Carvykti $102Iclusig $101Orserdu $96.17Itovebi $93.43Rybrevant $93.14Stivarga $92.07Vitrakvi $92.07Wayrilz $82.76Pomalyst $82.19Tukysa $81.81Krazati $81.13Talzenna $77.01Adcetris $72.09Vonjo $71.00Gavreto $69.07Balversa $67.96Phesgo $64.99Tecentriq Hybreza $64.62Tagrisso $63.45Provenge $57.54Venclexta $56.74Elahere $56.37Piqray $55.26Polivy $53.04Ultomiris $52.67Zoladex $52.37Qinlock $48.30Loqtorzi $45.95Xalkori $45.89Lorbrena $45.89Mektovi $45.89Braftovi $45.89Sylvant $45.10Rolvedon $43.48Zynlonta $42.99Synagis $40.14Ninlaro $37.26Optune Lua (Novottf-200t) $34.98Keytruda Qlex $33.05Lutathera $32.74Tevimbra $32.32Pylarify $31.68Besremi $31.40Lunsumio $30.80Odomzo $30.70
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Hok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.